Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Research reveals new insights into molecular circuitry controlling cancer growth and spread

Research reveals new insights into molecular circuitry controlling cancer growth and spread

Research shows tongue microbiome could help diagnose heart failure

Research shows tongue microbiome could help diagnose heart failure

Improving cancer therapies by exploiting drug resistance in cancer

Improving cancer therapies by exploiting drug resistance in cancer

Two potent small molecules appear to suppress tumor growth in multiple cancers

Two potent small molecules appear to suppress tumor growth in multiple cancers

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Damon Runyon Cancer Research Foundation awards $3.2 million to early-career physician-scientists

Study reveals novel mechanism that triggers a cell-mediated immune response

Study reveals novel mechanism that triggers a cell-mediated immune response

Key recommendations on genetic testing of men for prostate cancer

Key recommendations on genetic testing of men for prostate cancer

Study reveals new strategy to tackle cancer

Study reveals new strategy to tackle cancer

Tumors cause disruption of the immune system throughout the body, study finds

Tumors cause disruption of the immune system throughout the body, study finds

Rigidity of tissues drives immune system activity, UCLA study finds

Rigidity of tissues drives immune system activity, UCLA study finds

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Targeted therapy pralsetinib shows high response rates in patients with RET fusion-positive cancers

Research provides guidance for treating pancreatic cancer patients during COVID-19 pandemic

Research provides guidance for treating pancreatic cancer patients during COVID-19 pandemic

Platinum-based chemotherapy may improve outcomes for some metastatic pancreatic cancer patients

Platinum-based chemotherapy may improve outcomes for some metastatic pancreatic cancer patients

Scientists identify key cell signaling pathway that drives muscle loss

Scientists identify key cell signaling pathway that drives muscle loss

Researchers receive $5.75 million to study link between obesity, inflammation and pancreatic cancer

Researchers receive $5.75 million to study link between obesity, inflammation and pancreatic cancer

Understanding why pancreatic ductal adenocarcinoma is so aggressive

Understanding why pancreatic ductal adenocarcinoma is so aggressive

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

SWOG scientists to deliver online presentations at ASCO20 Virtual Scientific Program

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Fibroblasts of different pancreatic diseases exhibit distinct properties, study reveals

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Roswell Park team proposes possible new strategy for treating pancreatic cancer